Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Saatchi & Saatchi Consumer Healthcare has landed creative duties on the Plavix blood-thinning drug from Bristol-Myers Squibb and Sanofi-Synthelabo, a client representative said.
Estimated billings are $80 million.
Saatchi Consumer Healthcare, a New York-based unit of Publicis Groupe’s Saatchi & Saatchi, landed the business after a review involving Omnicom Group’s DDB, Grey Global Group’s Grey, Havas’ Euro RSCG MVBMS Partners and Health@JWT, a unit of WPP Group’s J. Walter Thompson, all in New York, said sources.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in